Altres ajuts: cofunded by European Union (ERDF/ESF, 'Investing in your future'). CIBERehd is supported by Instituto de Salud Carlos III, Spain. [ClinicalTrials.gov identifier: NCT02439567.]We aimed to investigate the early changes in liver and spleen stiffness measurement (LSM, SSM) in hepatitis C virus (HCV) patients with compensated advanced chronic liver disease (cACLD) treated with new antivirals (DAA) to elucidate factors determining the initial change in stiffness and its implications for the long-term follow up of HCV-cured patients. A total of 41 patients with cACLD who started DAA therapy underwent LSM and SSM at baseline, week 4, end of treatment (EOT), 24 and 48 weeks of follow up using transient elastography. LSM improved rapidl...
AIM to investigate changes in spleen stiffness measurements (SSMs) and other non-invasive tests (NIT...
The long-term changes of liver stiffness (LS) in patients who achieve viral clearance after direct-a...
Background & Objectives:Chronic hepatitis C is one of the leading causes of chronic liver diseas...
Background We aimed to investigate the early changes in liver and spleen stiffness measurement (LSM,...
Altres ajuts: cofunded by European Union (ERDF/ESF, 'Investing in your future'). CIBERehd is support...
BACKGROUND/AIMS:Liver stiffness (LS) measurement by means of transient elastography (TE) is accurate...
<div><h3>Background/Aims</h3><p>Liver stiffness (LS) measurement by means of transient elastography ...
International audienceAliment Pharmacol Ther 2011; 34: 656-663 SUMMARY: Background Transient elastog...
International audienceAliment Pharmacol Ther 2011; 34: 656-663 SUMMARY: Background Transient elastog...
Background/Aims: Liver stiffness (LS) measurement by means of transient elastography (TE) is accurat...
International audienceAliment Pharmacol Ther 2011; 34: 656-663 SUMMARY: Background Transient elastog...
International audienceAliment Pharmacol Ther 2011; 34: 656-663 SUMMARY: Background Transient elastog...
International audienceAliment Pharmacol Ther 2011; 34: 656-663 SUMMARY: Background Transient elastog...
Background/Aims: Liver stiffness (LS) measurement by means of transient elastography (TE) is accurat...
AIM to investigate changes in spleen stiffness measurements (SSMs) and other non-invasive tests (NIT...
AIM to investigate changes in spleen stiffness measurements (SSMs) and other non-invasive tests (NIT...
The long-term changes of liver stiffness (LS) in patients who achieve viral clearance after direct-a...
Background & Objectives:Chronic hepatitis C is one of the leading causes of chronic liver diseas...
Background We aimed to investigate the early changes in liver and spleen stiffness measurement (LSM,...
Altres ajuts: cofunded by European Union (ERDF/ESF, 'Investing in your future'). CIBERehd is support...
BACKGROUND/AIMS:Liver stiffness (LS) measurement by means of transient elastography (TE) is accurate...
<div><h3>Background/Aims</h3><p>Liver stiffness (LS) measurement by means of transient elastography ...
International audienceAliment Pharmacol Ther 2011; 34: 656-663 SUMMARY: Background Transient elastog...
International audienceAliment Pharmacol Ther 2011; 34: 656-663 SUMMARY: Background Transient elastog...
Background/Aims: Liver stiffness (LS) measurement by means of transient elastography (TE) is accurat...
International audienceAliment Pharmacol Ther 2011; 34: 656-663 SUMMARY: Background Transient elastog...
International audienceAliment Pharmacol Ther 2011; 34: 656-663 SUMMARY: Background Transient elastog...
International audienceAliment Pharmacol Ther 2011; 34: 656-663 SUMMARY: Background Transient elastog...
Background/Aims: Liver stiffness (LS) measurement by means of transient elastography (TE) is accurat...
AIM to investigate changes in spleen stiffness measurements (SSMs) and other non-invasive tests (NIT...
AIM to investigate changes in spleen stiffness measurements (SSMs) and other non-invasive tests (NIT...
The long-term changes of liver stiffness (LS) in patients who achieve viral clearance after direct-a...
Background & Objectives:Chronic hepatitis C is one of the leading causes of chronic liver diseas...